Review Article
Peroxisome Proliferator-Activated Receptor (PPAR): Balance for Survival in Parasitic Infections
Table 1
Effect of PPAR modulation on the outcome of parasitic infections.
| Parasite | Animal model | Treatment | PPAR status | Outcome | Reference |
| Increase in parasite load | | | | | |
| Leishmania major | Murine cutaneous leishmaniasis | Gene knockout | PPAR−/− macrophages | Decreased footpad swelling | [41] | Leishmania donovani | Murine visceral leishmaniasis | Curcumin | PPAR PPARα | Increased parasite load | [42] |
| Decrease in host tissue damage | | | | | |
| Schistosoma japonicum | Murine hepatic fibrosis | Rosiglitazone (Praziquantel) | PPAR | Decreased fibrosis | [60] | Plasmodium berghei | Murine cerebral malaria | Rosiglitazone | Not stated | Increased survival | [57] | Plasmodium chabaudi | Murine malaria | Rosiglitazone | Not stated | Decreased parasitemia | [57] |
|
|